These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21605719)

  • 1. Viral reactivation and drug rash: causal or casual association?
    Krishna CV
    Am J Med; 2011 Jun; 124(6):e7. PubMed ID: 21605719
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug rash with eosinophilia and systemic symptoms syndrome associated with clindamycin.
    Tian D; Mohan RJ; Stallings G
    Am J Med; 2010 Nov; 123(11):e7-8. PubMed ID: 20843501
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal clindamycin-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome.
    Miller Quidley A; Bookstaver PB; Gainey AB; Gainey MD
    Pharmacotherapy; 2012 Dec; 32(12):e387-92. PubMed ID: 23165860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug rash with eosinophilia and systemic symptoms and graft-versus-host disease developing sequentially in a patient.
    Natkunarajah J; Watson K; Diaz-Cano S; Mufti G; du Vivier A; Creamer D
    Clin Exp Dermatol; 2009 Mar; 34(2):199-201. PubMed ID: 18793307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe vancomycin-induced drug rash with eosinophilia and systemic symptoms syndrome imitating septic shock.
    Boet S; Noblet C; Haas-Hubscher C; Picard D; Musette P; Dureuil B
    Eur J Anaesthesiol; 2009 Sep; 26(9):791-3. PubMed ID: 19424074
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute generalized exanthematous pustulosis induced by clindamycin.
    Kapoor R; Flynn C; Heald PW; Kapoor JR
    Arch Dermatol; 2006 Aug; 142(8):1080-1. PubMed ID: 16924073
    [No Abstract]   [Full Text] [Related]  

  • 7. Vancomycin-induced DRESS syndrome in a female patient.
    Vauthey L; Uçkay I; Abrassart S; Bernard L; Assal M; Ferry T; Djordjevic M; Roussos C; Vaudaux P
    Pharmacology; 2008; 82(2):138-41. PubMed ID: 18607115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced hypersensitivity syndrome induced by clindamycin.
    Nakamura Y; Watamatsu K; Muto M
    Acta Derm Venereol; 2013 Jan; 93(1):83-4. PubMed ID: 22855006
    [No Abstract]   [Full Text] [Related]  

  • 9. A recurrent drug rash with eosinophilia and systemic symptoms.
    Ben Salem C; Slim R; Denguezli M; Nouira R; Hmouda H; Bouraoui K
    Pediatr Dermatol; 2007; 24(6):666-8. PubMed ID: 18035998
    [No Abstract]   [Full Text] [Related]  

  • 10. [Glycopeptide-induced cutaneous adverse reaction].
    Nosbaum A; Rozières A; Ben Said B; Nicolas JF; Bérard F
    Ann Dermatol Venereol; 2010 May; 137(5):341-2. PubMed ID: 20470913
    [No Abstract]   [Full Text] [Related]  

  • 11. SDRIFE-like reaction induced by an intradermal skin test with clindamycin: A case report.
    Morales-Cabeza C; Caralli Bonett ME; Micozzi S; Seoane Rodríguez M; Rojas-Pérez-Ezquerra P; de Barrio Fernández M
    J Allergy Clin Immunol Pract; 2015; 3(6):976-7. PubMed ID: 26164811
    [No Abstract]   [Full Text] [Related]  

  • 12. DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6.
    Tamagawa-Mineoka R; Katoh N; Nara T; Nishimura Y; Yamamoto S; Kishimoto S
    Int J Dermatol; 2007 Jun; 46(6):654-5. PubMed ID: 17550572
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug rash with eosinophilia and systemic symptoms (DRESS): changing carbamazepine to phenobarbital controlled epilepsy without the recurrence of DRESS.
    Inadomi T
    Eur J Dermatol; 2010; 20(2):220-2. PubMed ID: 20103499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of amoxicillin induced peripheral thrombocytopenia: about one case.
    Ksouda K; Affes H; Lahieni D; Maaloul I; Sahnoun Z; Ben Jmeaa M; Zeghal KM; Hammami S
    Therapie; 2013; 68(3):171-2. PubMed ID: 23886463
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug rash with eosinophilia and systemic symptoms syndrome induced by sulfasalazine.
    Bahat G; Celik HG; Tufan F; Saka B
    Joint Bone Spine; 2010 Jan; 77(1):87-8. PubMed ID: 19854669
    [No Abstract]   [Full Text] [Related]  

  • 16. [On iatrogenic damage caused by chemoantibiotic therapy of chronic bronchopneumopathies].
    Serra C
    Minerva Med; 1971 Feb; 62(16):770-5. PubMed ID: 4251442
    [No Abstract]   [Full Text] [Related]  

  • 17. DRESS like severe drug rash with eosinophilia, atypic lymphocytosis and fever secondary to ceftriaxone.
    Akcam FZ; Aygun FO; Akkaya VB
    J Infect; 2006 Aug; 53(2):e51-3. PubMed ID: 16352341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin.
    Wendland T; Daubner B; Pichler WJ
    Br J Clin Pharmacol; 2011 Feb; 71(2):297-300. PubMed ID: 21219413
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug rash with eosinophilia and systemic symptoms induced by cefotaxime and ampicillin.
    Fujiwaki T; Yoshikawa T; Urashima R; Ishioka C
    Pediatr Int; 2008 Jun; 50(3):406-8. PubMed ID: 18533962
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed reaction to oral treatment with clindamycin.
    Vicente J; Fontela JL
    Contact Dermatitis; 1999 Oct; 41(4):221. PubMed ID: 10515103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.